» Articles » PMID: 37585915

A Model for Preservation of Thymocyte-depleted Thymus

Overview
Date 2023 Aug 16
PMID 37585915
Authors
Affiliations
Soon will be listed here.
Abstract

DiGeorge syndrome is a disorder caused by a microdeletion on the long arm of chromosome 22. Approximately 1% of patients diagnosed with DiGeorge syndrome may have an absence of a functional thymus, which characterizes the complete form of the syndrome. These patients require urgent treatment to reconstitute T cell immunity. Thymus transplantation is a promising investigational procedure for reconstitution of thymic function in infants with congenital athymia. Here, we demonstrate a possible optimization of the preparation of thymus slices for transplantation through prior depletion of thymocytes and leukocyte cell lineages followed by cryopreservation with cryoprotective media (5% dextran FP 40, 5% Me2SO, and 5% FBS) while preserving tissue architecture. Thymus fragments were stored in liquid nitrogen at -196°C for 30 days or one year. The tissue architecture of the fragments was preserved, including the distinction between medullary thymic epithelial cells (TECs), cortical TECs, and Hassall bodies. Moreover, depleted thymus fragments cryopreserved for one year were recolonized by intrathymic injections of 3×106 thymocytes per mL, demonstrating the capability of these fragments to support T cell development. Thus, this technique opens up the possibility of freezing and storing large volumes of thymus tissue for immediate transplantation into patients with DiGeorge syndrome or atypical (Omenn-like) phenotype.

References
1.
Markert M, Devlin B, McCarthy E . Thymus transplantation. Clin Immunol. 2010; 135(2):236-46. PMC: 3646264. DOI: 10.1016/j.clim.2010.02.007. View

2.
Hong R, Moore A . Organ culture for thymus transplantation. Transplantation. 1996; 61(3):444-8. DOI: 10.1097/00007890-199602150-00023. View

3.
Markert M, Marques J, Neven B, Devlin B, McCarthy E, Chinn I . First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases. Blood. 2010; 117(2):688-96. PMC: 3031487. DOI: 10.1182/blood-2010-06-292490. View

4.
Davies E . Immunodeficiency in DiGeorge Syndrome and Options for Treating Cases with Complete Athymia. Front Immunol. 2013; 4:322. PMC: 3814041. DOI: 10.3389/fimmu.2013.00322. View

5.
Wang S, Mundada L, Johnson S, Wong J, Witt R, Ohye R . Characterization and angiogenic potential of human neonatal and infant thymus mesenchymal stromal cells. Stem Cells Transl Med. 2015; 4(4):339-50. PMC: 4367509. DOI: 10.5966/sctm.2014-0240. View